Clinical trials
Bipolar Disorder I or II clinical trials
Below are recruiting bipolar disorder i or ii clinical trials, each written for real people, not researchers. We’re tracking 2,350 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06232473RecruitingPhase 4
Education and duloxetine for multisystem functional somatic disorder
This trial tests whether a combination of patient education and the medication duloxetine can help people with a condition that causes multiple unexplained physical symptoms (functional somatic disorder). It aims to see if using both treatments together works better than either alone.
AarhusAges 18–60 - NCT04602325Recruiting
Blood and brain injury biomarker study for inherited metabolic disorders
This trial studies blood and other measurable signs (biomarkers) that may reflect brain injury after certain inherited metabolic conditions. Results may help doctors better detect and understand brain effects from these illnesses, especially episodes that affect the brain.
Washington D.C., District of ColumbiaAges 7–18 - NCT07873060Recruiting
Brain stimulation for depression in teens
This study compares two types of non-invasive brain stimulation (using magnetic pulses) to see which works better for teenagers with depression. It aims to find a safe, effective treatment that may help improve mood without medication.
Jinan, ShandongAges 11–19 - NCT06272149RecruitingEarly Phase 1
Gene Therapy for Infants With Type 2 Gaucher Disease
This trial tests a new gene therapy (VGN-R08b) for infants with Type 2 Gaucher disease, a rare genetic condition that affects the brain and body. The goal is to see if the treatment is safe and can help improve symptoms.
Shanghai, Shanghai MunicipalityAges birth–2 years - NCT05995769RecruitingPhase 2
Psilocybin therapy with talk therapy for alcohol problems
This trial tests whether psilocybin (the active ingredient in magic mushrooms), given with talk therapy, can help people who want to reduce their heavy drinking. It is for people with at least moderate alcohol use disorder who are motivated to change.
Calgary, AlbertaAges 22–65 - NCT06018272Recruiting
Mentalization therapy for borderline personality disorder
This trial compares a therapy called mentalization-based treatment with other proven therapies for people with borderline personality disorder. It aims to find out which approach works better for reducing self-harm and suicidal behaviors.
BerlinAges 18–65 - NCT04201210RecruitingPhase 2
Stem cell transplant study for young people with severe sickle cell
This Phase 2 study tests a type of stem cell transplant that uses donor immune cells that have been specially “tweaked” to help treat sickle cell disease. It may help prevent serious sickle cell complications, but it requires careful matching and screening of organs and pregnancy status.
ViennaAges 2–35 - NCT07844694RecruitingPhase 1
Low-dose sirolimus for patients with RUNX1 platelet disorder
This trial tests whether a low dose of sirolimus, a drug that calms the immune system, can help improve blood counts and reduce bleeding risk in people with a genetic condition called RUNX1 familial platelet disorder. If it works, it might lower the chance of developing serious blood problems later.
Portland, OregonAges 18 years+ - NCT07834567Recruiting
Mindfulness-based cognitive therapy for obsessive-compulsive disorder
This study tests whether an online mindfulness-based cognitive therapy program can help improve symptoms in people with obsessive-compulsive disorder (OCD). It also looks at how the brain and body respond to the treatment, aiming to find better ways to manage OCD.
BresciaAges 18–45 - NCT07840417Recruiting
Deep brain reorienting therapy for PTSD in veterans
This study tests a new type of talk therapy called deep brain reorienting (DBR) for veterans with post-traumatic stress disorder (PTSD). It aims to help your brain process traumatic memories and reduce PTSD symptoms over 8 sessions.
Edmonton, AlbertaAges 18–65 - NCT07825818RecruitingEarly Phase 1
Brain scan study for heavy drinkers
This study uses a special brain scan to look at how alcohol use affects energy production in brain cells. It may help researchers find new ways to treat alcohol use disorder.
Pittsburgh, PennsylvaniaAges 18–55 - NCT06318806Recruiting
OCD recovery study: therapy for full remission
This study tests a psychological treatment aimed at helping people with obsessive-compulsive disorder (OCD) reach full recovery. It is done remotely using your computer or phone, so you can participate from home.
Montreal, QuebecAges 18 years+ - NCT07807865RecruitingPhase 3
Testing a new anxiety medication for safety
This study is testing a new medication for generalized anxiety disorder. It will check if the drug is safe and well-tolerated when taken alone or alongside your current anxiety treatment.
Los Angeles, CaliforniaAges 18 years+ - NCT07799493RecruitingPhase 4
Studying caplyta for adults with social anxiety disorder
This study tests whether the medication caplyta (lumateperone) helps reduce symptoms of social anxiety disorder compared to a placebo. If it works, it could give people a new treatment option.
New York, New YorkAges 18–65 - NCT07787949Recruiting
Platelet-rich fibrin injection for gum bone defects
This study tests a new way to treat a specific type of gum disease that causes bone loss around the roots of back teeth. It uses your body's own healing factors (from a blood sample) to help the bone and gum reattach, without surgery.
Giza, Giza GovernorateAges 18 years+ - NCT06542224Recruiting
Finding Brain Signals to Guide OCD Deep Brain Stimulation
This study is testing whether brain signals measured during deep brain stimulation (DBS) can help doctors better treat Obsessive-Compulsive Disorder. It may offer a new way to personalize treatment for people with severe, treatment-resistant OCD.
Chengdu, SichuanAges 18–65 - NCT07767903RecruitingPhase 3
Study of a new medicine for generalized anxiety disorder
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
Redlands, CaliforniaAges 18 years+ - NCT07775300RecruitingPhase 3
Study of an injectable drug for major depressive disorder
This study tests an investigational drug called brenipatide for major depressive disorder. It is given as a self-injection and is being compared to a placebo to see if it helps improve depression symptoms in people who are already on standard treatment.
Birmingham, AlabamaAges 18–75 - NCT07773649RecruitingEarly Phase 1
PET scan to study energy use in brain of people with cocaine use disorder
This study uses a special PET scan to look at how brain cells make energy, which may be changed by cocaine. It might help researchers find better ways to treat cocaine use disorder.
Pittsburgh, PennsylvaniaAges 18–45 - NCT07768397Recruiting
Comparing two brain-stimulation schedules for depression
This study tests two different schedules of a treatment called theta burst stimulation, which uses magnetic pulses to gently stimulate the brain. It aims to find out if the faster schedule works better than the standard one for people with major depression.
Ho Chi Minh CityAges 18–65 - NCT07772401Recruiting
Ear stimulation for social anxiety disorder
This study tests whether a gentle electrical pulse through the ear can help reduce symptoms of social anxiety. It's a non-invasive treatment that may offer a new way to manage anxiety without medication.
Hangzhou, ZhejiangAges 18–70 - NCT07770919Recruiting
Brain stimulation for generalized anxiety disorder
This study tests a non-invasive brain stimulation technique (called continuous theta burst stimulation) to see if it can reduce symptoms of generalized anxiety disorder. The treatment uses magnetic pulses to target areas of the brain involved in anxiety, and it may help if standard treatments haven't worked well.
Ho Chi Minh CityAges 18–65 - NCT06570057Recruiting
Community program to prevent type 2 diabetes in Karachi
This study tests a community-based program in Karachi to help prevent type 2 diabetes and manage related risks. It welcomes adults with any blood sugar level, from normal to diabetes, to see if group support and education can make a difference.
Karachi, SindhAges 20 years+ - NCT07759154RecruitingPhase 3
A study of centanafadine for adults with ADHD and emotional symptoms
This study tests an investigational medicine called centanafadine for adults with ADHD who also have trouble managing their emotions. The goal is to see if the medicine can help improve both attention and emotional control.
Gainesville, FloridaAges 18–65
Hear when a new Bipolar Disorder I or II trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for bipolar disorder i or ii?
- Yes. Clin2 currently lists 2,350 recruiting bipolar disorder i or ii studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bipolar disorder i or ii trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bipolar disorder i or ii trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.